Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezekowitz

Showing results (801-810 of 842) with videos related to

Pageof 85
Sort By:
Journal of Cardiac Failure|April 3, 2012
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines CommitteeJaved Butler, Justin A Ezekowitz, Sean P Collins, et al.
Journal of Cardiac Failure|February 4, 2012
Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline CommitteeWilliam G Stevenson, Adrian F Hernandez, Peter E Carson, et al.
BMC Cardiovascular Disorders|July 27, 2014
The Alberta Heart Failure Etiology and Analysis Research Team (HEART) studyJustin A Ezekowitz, Harald Becher, Israel Belenkie, et al.
Circulation|September 8, 2023
Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection FractionJesse D Cochran, Yoshimitsu Yura, Mark C Thel, et al.
European Journal of Heart Failure|September 29, 2025
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trialRobert J Mentz, Javed Butler, Ciaran J McMullan, et al.
Journal of the American College of Cardiology|September 2, 2025
Effect of Vericiguat on Worsening Heart Failure in Compensated Outpatients with HFrEF: Insights from VICTORFaiez Zannad, Yogesh N V Reddy, Irina Barash, et al.
American Heart Journal|September 6, 2025
Rationale and Design of the Comparative Effectiveness of ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients at a Low Risk for Arrhythmic Death (CONTEMP-ICD) trialIlan Goldenberg, Wojciech Zareba, Justin A Ezekowitz, et al.
The American Journal of Medicine|April 30, 2016
North American Thrombosis Forum, AF Action Initiative Consensus DocumentChristian T Ruff, Jack E Ansell, Richard C Becker, et al.
Journal of Cardiac Failure|June 8, 2013
Acute decompensated heart failure: update on new and emerging evidence and directions for future researchMichael M Givertz, John R Teerlink, Nancy M Albert, et al.
European Journal of Heart Failure|July 3, 2025
Changes in natriuretic peptide levels following patiromer-enabled optimization of medical therapy in heart failure: A post hoc analysis of the DIAMOND studyAndreas P Kalogeropoulos, Ishaque Hameed, Stefan D Anker, et al.
Pageof 85

Showing results (801-810 of 842) with videos related to

Sort By:
Pageof 85
Journal of Cardiac Failure|April 3, 2012
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines CommitteeJaved Butler, Justin A Ezekowitz, Sean P Collins, et al.
Journal of Cardiac Failure|February 4, 2012
Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline CommitteeWilliam G Stevenson, Adrian F Hernandez, Peter E Carson, et al.
BMC Cardiovascular Disorders|July 27, 2014
The Alberta Heart Failure Etiology and Analysis Research Team (HEART) studyJustin A Ezekowitz, Harald Becher, Israel Belenkie, et al.
Circulation|September 8, 2023
Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection FractionJesse D Cochran, Yoshimitsu Yura, Mark C Thel, et al.
European Journal of Heart Failure|September 29, 2025
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trialRobert J Mentz, Javed Butler, Ciaran J McMullan, et al.
Journal of the American College of Cardiology|September 2, 2025
Effect of Vericiguat on Worsening Heart Failure in Compensated Outpatients with HFrEF: Insights from VICTORFaiez Zannad, Yogesh N V Reddy, Irina Barash, et al.
American Heart Journal|September 6, 2025
Rationale and Design of the Comparative Effectiveness of ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients at a Low Risk for Arrhythmic Death (CONTEMP-ICD) trialIlan Goldenberg, Wojciech Zareba, Justin A Ezekowitz, et al.
The American Journal of Medicine|April 30, 2016
North American Thrombosis Forum, AF Action Initiative Consensus DocumentChristian T Ruff, Jack E Ansell, Richard C Becker, et al.
Journal of Cardiac Failure|June 8, 2013
Acute decompensated heart failure: update on new and emerging evidence and directions for future researchMichael M Givertz, John R Teerlink, Nancy M Albert, et al.
European Journal of Heart Failure|July 3, 2025
Changes in natriuretic peptide levels following patiromer-enabled optimization of medical therapy in heart failure: A post hoc analysis of the DIAMOND studyAndreas P Kalogeropoulos, Ishaque Hameed, Stefan D Anker, et al.
Pageof 85